Corporate borrowers shrugged off fears over inflation and concerns over tariffs to print tight trades and pay for ...
Eli Lilly and RNAi therapeutics specialist OliX Pharmaceuticals have entered into a global licensing agreement to advance a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback